GlassScriptPhysician profile
Stephanie Vulcano
NPI 1558051110
$515.16
in general payments reported to CMS, 2019-2025
10 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $87.86 · 2024: $325 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urgo Medical North America, LLC | $147.17 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Biofrontera INC. | $67.89 | 2023-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Convatec INC. | $52.27 | 2024 | |
| Mimedx Group, INC. | $49.83 | 2024 | |
| Integra Lifesciences Corporation | $49.46 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Lilly USA, LLC | $37.68 | 2024 | Taltz |
| Genzyme Corporation | $30.55 | 2024 | |
| Ucb, INC. | $28.89 | 2025 | Bimzelx |
| Leo Pharma INC. | $26.72 | 2025 | Adbry |
| Novartis Pharmaceuticals Corporation | $24.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Vulcano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.